Published on in Vol 4, No 9 (2020): September
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/17126, first published
.
![Lifestyle Interventions for Polycystic Ovary Syndrome: Cross-Sectional Survey to Assess Women's Treatment and Outcome Preferences Lifestyle Interventions for Polycystic Ovary Syndrome: Cross-Sectional Survey to Assess Women's Treatment and Outcome Preferences](https://asset.jmir.pub/assets/06335a97da17247e37159e35f22e0450.png 480w,https://asset.jmir.pub/assets/06335a97da17247e37159e35f22e0450.png 960w,https://asset.jmir.pub/assets/06335a97da17247e37159e35f22e0450.png 1920w,https://asset.jmir.pub/assets/06335a97da17247e37159e35f22e0450.png 2500w)
Journals
- Cignarella A, Mioni R, Sabbadin C, Dassie F, Parolin M, Vettor R, Barbot M, Scaroni C. Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS. International Journal of Molecular Sciences 2020;21(24):9554 View
- Liu Z, Song Y, Xu Y, Wang J, Hu H, Weng Y. The comparison of the effectiveness and safety of drospirone ethinyl estradiol and ethinyl estradiol cyproterone in the treatment of polycystic ovarian syndrome. Medicine 2020;99(51):e23811 View
- Choi H, Lee S, Yang S. Development of an integrated mobile application for lifestyle modification in women with polycystic ovarian syndrome. Journal of Clinical Nursing 2023;32(1-2):49 View
- H. Al Wattar B, M. Hussain N, S. Khan K. Lifestyle interventions in women with polycystic ovary syndrome: A scoping systematic review of randomised evidence. Medicina de Familia. SEMERGEN 2022;48(3):186 View